Literature DB >> 2838579

Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.

H Ishii1, Y Kobayashi, M Kuroki, Y Kodama.   

Abstract

Virus envelope glycoprotein gVI (gp50) of Aujeszky's disease virus (ADV) was purified from a Nonidet P40-solubilized lysate of ADV-infected Vero cells by immunoaffinity chromatography using a monoclonal antibody against gVI. Mice immunized by the purified gVI produced virus-neutralizing antibody and were successfully protected against subsequent challenge with ADV.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2838579     DOI： 10.1099/0022-1317-69-6-1411

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  6 in total

1.  Identification of pseudorabies virus-exposed swine with a gI glycoprotein enzyme-linked immunosorbent assay.

Authors:  M W Mellencamp; N E Pfeiffer; B T Suiter; J R Harness; W H Beckenhauer
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

2.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

Authors:  I Rauh; T C Mettenleiter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.

Authors:  S Heffner; F Kovács; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.

Authors:  M Riviere; J Tartaglia; M E Perkus; E K Norton; C M Bongermino; F Lacoste; C Duret; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Induction of protective immunity and neutralizing antibodies to pseudorabies virus by immunization of anti-idiotypic antibodies.

Authors:  T Tsuda; T Onodera; T Sugimura; Y Murakami
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.